Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Relay Medical Corp. (C:RELA)

Business Focus: Medical Diagnostic & Testing Equipment

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for RELA within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Feb 27, 2020 16:05 ET
Relay Medical announces Provisional Patent for POCT CO-oximetry Technology; Launches HemoPalm website in Mandarin
Toronto, Ontario--(Newsfile Corp. - February 27, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company"), a developer of MedTech innovation, is pleased to announce the filing of a provisional patent entitled Precision Optical Chambers Device, System, and Method of Manufacturing Same, for its HemoPalm-CX Point-of-Care Testing (POCT) CO-Oximetry device.
Read full article
Feb 25, 2020 16:55 ET
Correction - Relay Medical announces completion of HemoPalm(TM) Proof-of-Principle CO-oximeter Prototype, a Proprietary, State-of-the-Art, Point-of-Care Technology
Toronto, Ontario--(Newsfile Corp. - February 25, 2020) - Relay Medical Corp. (CSE: RELA) (OTCQB: RYMDF) (FSE: EIY2) ("Relay" or the "Company") , a developer of MedTech innovation, is pleased to announce the completion of the HemoPalm-CX™, a proof-of-principle prototype compact POCT instrument that directly measures five CO-oximetry components from human whole blood. The system uses proprietary optics and data analysis technology developed by the Company's HemoPalm diagnostics division. This correction is being issued to fix a typo in the headline where HemoPal(TM) should have read HemoPalm(TM). The corrected release in its entirety is being issued below.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-0.17
--
--
Price to Sales - TTM
--
55.88
9.20
Price to Book - most recent quarter
19.50
1.53
1.89
Price to Cash Flow per share - TTM
--
--
9.51
Price to Free Cash Flow per share - TTM
--
--
18.57
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Feb 15, 20201,083-26,471
Jan 31, 202027,55419,215
Jan 15, 20208,3390
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Relay Medical Corp, formerly ChroMedX Corp, is a Canada-based medical technology company. The Company focuses on the development of handheld medical devices for In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). The Company's devices are protected by issued United States and pending international patents, in the medical diagnostics and research field, dealing with blood collection, analysis and plasma/serum processing. The Company has the following platform technologies: HemoPalm and Automated Ultra Filtration (AUF) technology. Its HemoPalm platform is a blood analysis system consisting of a handheld analyzer and a suite of disposable single use cartridges. Its UAF technology allows the preparation of ultra-filtrates of serum and plasma samples, for measurement of therapeutic drugs and hormones to be done on an automated system.

See business summary

Twitter

Search (past week) for $RELA.CA

  • No tweets found